Newsfeeds Archive - Page 3 of 3

2 minute read

RadNet’s Artificial Intelligence Subsidiary, DeepHealth, Announces FDA Clearance Of Its Third AI Mammography Product

December 19, 7:08 AM

RadNet, Inc. (NASDAQ:RDNT), today announced that its subsidiary DeepHealth, Inc., a leading developer of artificial intelligence (AI) for mammography interpretation, has received FDA clearance of its mammography density

RDNT

4 minute read

Delaware Imaging Network, A Division Of RadNet, Inc. Launches The Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered By Artificial Intelligence

By Benzinga Newsdesk

December 5, 12:14 PM

Delaware Imaging Network, a division of RadNet, Inc. (NASDAQ:RDNT), today announced that it has started implementation of its new Enhanced Breast Cancer Detection (EBCD) service (https://myEBCDmammo.com), which works in

RDNT

8 minute read

Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday

By Lisa Levin

November 10, 6:12 AM

Gainers

$APE

16 minute read

Options

Stocks That Hit 52-Week Lows On Wednesday

By Benzinga Insights

November 9, 2:45 PM

On Wednesday, 283 companies set new 52-week lows.

ACHL

6 minute read

Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

November 9, 1:33 PM

Gainers

ABST

1 minute read

RadNet Forecasts Lower Profits In 2022 Due To Rising Costs, Labor Shortage

By Vandana Singh

November 9, 12:56 PM

RadNet Inc (NASDAQ:RDNT) reported Q3 adjusted EPS of $0.09, down from $0.21 a year ago and missing the consensus of…

RDNT

5 minute read

Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday

By Lisa Levin

September 29, 5:09 AM

Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial met its primary endpoint.

ABOS

4 minute read

Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday’s Mid-Day Session

By Lisa Levin

September 28, 12:40 PM

Gainers

ABOS

1 minute read

RadNet Q2 EPS $0.15 Beats $0.07 Estimate, Sales $354.40M Beat $348.94M Estimate

By Benzinga Newsdesk

August 9, 6:00 AM

RadNet (NASDAQ:RDNT) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.07 by 114.29 percent. This is a 44.44 percent decrease over earnings of $0.27 per share from the same

RDNT